Recent News

August 31, 2021

Catalyst OrthoScience Features Innovative Products, Surgical Leaders And Archer™ 3D Targeting Imaging Software At AAOS

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
August 24, 2021

Catalyst OrthoScience Introduces Archer™ 3D Targeting Imaging Software For Preoperative Planning

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
May 5, 2021

Catalyst OrthoScience Announces First Surgeries Using Archer™ R1 Reverse Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
April 28, 2021

Catalyst OrthoScience Gains Momentum As It Introduces The Archer™ R1 Reverse Shoulder System And Rebrands Its Archer™ CSR Total Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
March 17, 2021

Catalyst OrthoScience Receives FDA 510(k) Clearance Of Its Reverse Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
February 17, 2021

Newly Published Study With The Stemless Catalyst CSR™ Total Shoulder System Demonstrates Good Results In Adult Arthroplasty Patients Of All Ages At 2-3 Year Follow-Up

Published peer reviewed study show significant improvements in motion and patient-reported measures in adult shoulder replacement patients of all ages.
January 27, 2021

Catalyst In The News: Hand and Upper Limb Orthopedic Surgeon Dr. Badia Says Partial Shoulder Reconstruction Option for More Patients and Ideal for Outpatient Surgery; Offers Tips

October 14, 2020

Virtual Reality Brings The Future Of Shoulder Arthroplasty To Surgeons With Catalyst OrthoScience, Immertec Technologies

With the ongoing pandemic affecting in-person meetings and travel, two companies worked to bring surgeon training into the future using virtual reality (VR). Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, presented a training lab for surgeons across the country using Immertec’s proprietary VR platform Medoptic.
October 17, 2019

Catalyst OrthoScience Features Two New Products, William Levine, MD Presents The Catalyst CSR™ Total Shoulder System at ASES 2019 Annual Meeting

William Levine, MD presents the Catalyst CSR™ Total Shoulder System, including two new components, during the 2019 ASES meeting on Saturday, Oct. 19.
May 14, 2019

Catalyst OrthoScience Closes $12.7 Million Oversubscribed Financing Round to Fuel Growth of Novel Total Shoulder System

Catalyst OrthoScience has raised $12.7 million in an oversubscribed Series C-1 financing round led by River Cities Capital Funds.